These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 13476356)

  • 1. Pharmacology of d-lysergic acid morpholide (LSM).
    GOGERTY JH; DILLE JM
    J Pharmacol Exp Ther; 1957 Jul; 120(3):340-8. PubMed ID: 13476356
    [No Abstract]   [Full Text] [Related]  

  • 2. Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).
    Brandt SD; Kavanagh PV; Twamley B; Westphal F; Elliott SP; Wallach J; Stratford A; Klein LM; McCorvy JD; Nichols DE; Halberstadt AL
    Drug Test Anal; 2018 Feb; 10(2):310-322. PubMed ID: 28585392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the pharmacology of D-lysergic acid cycloalkylamides.
    VOTAVA Z; PODVALOVA I; SEMONSKY M
    Arch Int Pharmacodyn Ther; 1958 May; 115(1-2):114-30. PubMed ID: 13545891
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacology of d-lysergic acid cycloalkylamides].
    VOTAVA Z
    J Physiol (Paris); 1957; 49(1):417-9. PubMed ID: 13449863
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of d-lysergic acid diethylamide and related compounds on melanophores].
    BERDE B; CERLETTI A
    Helv Physiol Pharmacol Acta; 1956; 14(3):325-33. PubMed ID: 13405353
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.
    GRAHAM JR
    N Engl J Med; 1960 Dec; 263():1273-7. PubMed ID: 13707731
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological properties of d-lysergic acid cycloalkylamides].
    VOTAVA Z; PODVALOVA I
    Cas Lek Cesk; 1958 Aug; 97(34):1062-6. PubMed ID: 13597011
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on lysergic acid diethylamide and related compounds. Part 8. Structural identification of new metabolites of lysergic acid diethylamide obtained by microbial transformation using Streptomyces roseochromogenes.
    Ishii H; Niwaguchi T; Nakahara Y; Hayashi M
    J Chem Soc Perkin 1; 1980; 4():902-5. PubMed ID: 7190156
    [No Abstract]   [Full Text] [Related]  

  • 9. [Uterotonic effect of d-lysergic acid cyclopentylamides in postpartum women].
    KOUTSKY J
    Cas Lek Cesk; 1958 Aug; 97(34):1067-9. PubMed ID: 13597012
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on lysergic acid diethylamide and related compounds. IV. Syntheses of various amide derivatives of norlysergic acid and related compounds].
    Niwaguchi T; Nakahara Y; Ishii H
    Yakugaku Zasshi; 1976 May; 96(5):673-8. PubMed ID: 987200
    [No Abstract]   [Full Text] [Related]  

  • 11. [Psychopathological experiences with the combined action of lysergic acid mono- & diethylamide (LAE-32, LSD-25)].
    CALLIERI B; RAVETTA M
    Riv Sper Freniatr Med Leg Alien Ment; 1957 Jul; 81(2):267-313. PubMed ID: 13466954
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on lysergic acid diethylamide and related compounds. VII. Microbial transformation of lysergic acid diethylamide and related compounds.
    Ishii H; Hayashi M; Niwaguchi T; Nakahara Y
    Chem Pharm Bull (Tokyo); 1979 Jul; 27(7):1570-5. PubMed ID: 540347
    [No Abstract]   [Full Text] [Related]  

  • 13. Lysergic acid diethylamide (LSD-25). XXXI. Comparison by questionnaire of psychotomimetic activity of congeners on normal subjects and drug addicts.
    ABRAMSON HA
    J Ment Sci; 1960 Jul; 106():1120-3. PubMed ID: 13681136
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of monoethylamide (LAE) and diethylamide (LSD) of lysergic acid on behavior of mouse with imino-beta, beta-dipropionitrile induced circular movement].
    WIDLOCHER D; NAKAJIMA H; THUILLIER J
    C R Seances Soc Biol Fil; 1957; 151(4):668-70. PubMed ID: 13489946
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE EFFECT OF D-LYSERGIC ACID DIETHYLAMIDE ON HIGHER NERVOUS ACTIVITY IN MONKEYS].
    LAGUTINA NI; LARICHEVA KA; MILSHTEIN GI; NORKINA LN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1963; 13():638-45. PubMed ID: 14059202
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study on the serotonin antagonism of amide derivatives of lysergic acid and of ergot alkaloids.
    CERLETTI A; DOEPFNER W
    J Pharmacol Exp Ther; 1958 Jan; 122(1):124-36. PubMed ID: 13502837
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of the antagonistic psychopathological effects of lysergic acid monoethylamide (LAE-32) & methylphenylisopropylamine (pervitin)].
    CALLIERI B; RAVETTA M
    Rass Neuropsichiatr; 1957; 11(3-4):198-216. PubMed ID: 13506109
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapeutic trials in psychosis. III. Addendum-2-brom-d-lysergic acid diethylamide (BOL).
    TURNER WJ; ALMUDEVAR M; MERLIS S
    Am J Psychiatry; 1959 Sep; 116():261-2. PubMed ID: 13839967
    [No Abstract]   [Full Text] [Related]  

  • 19. Some pharmacological actions of D-lysergic acid methyl carbinolamide.
    GLASSER A
    Nature; 1961 Jan; 189():313-4. PubMed ID: 13705953
    [No Abstract]   [Full Text] [Related]  

  • 20. [Butanolamide of 1-methyl-D-lysergic acid and histamine liberation].
    LECOMTE J; LAPIERE CM
    C R Seances Soc Biol Fil; 1960; 154():2386-9. PubMed ID: 13760117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.